← All indications
Hepatitis, Autoimmune
A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
Drugs by status
Phase 4 trials (8)
Phase 2 trials (8)
Phase 1 trials (4)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (19)
- Veloxis Pharmaceuticals
- Iltoo Pharma
- University of Manitoba
- Baylor University
- Nanjing Medical University
- Northwestern University
- University of Miami
- University of Adelaide
- University of Alberta
- University of Birmingham
- Virginia Commonwealth University
- Mayo Clinic
- University of Calgary
- Icahn School of Medicine at Mount Sinai
- University of Minnesota
- University of Paris
- European Union
- BioIncept LLC
- Stero Biotechs Ltd.
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (1)